Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | SYRS |
---|---|---|
09:32 ET | 59771 | 0.2667 |
09:33 ET | 12216 | 0.2675 |
09:35 ET | 9841 | 0.270349 |
09:37 ET | 11598 | 0.2731 |
09:39 ET | 29254 | 0.2656 |
09:42 ET | 92687 | 0.2741 |
09:44 ET | 22221 | 0.2721 |
09:46 ET | 31335 | 0.272 |
09:48 ET | 23738 | 0.2751 |
09:50 ET | 7047 | 0.2727 |
09:51 ET | 22626 | 0.270249 |
09:53 ET | 15431 | 0.267801 |
09:55 ET | 42579 | 0.26995 |
09:57 ET | 6832 | 0.27095 |
10:00 ET | 6576 | 0.27359 |
10:02 ET | 3375 | 0.2692 |
10:04 ET | 5614 | 0.271 |
10:06 ET | 59632 | 0.2743 |
10:08 ET | 2845 | 0.2704 |
10:09 ET | 17921 | 0.26831 |
10:11 ET | 9889 | 0.27 |
10:13 ET | 35343 | 0.27 |
10:15 ET | 14527 | 0.2709 |
10:18 ET | 24098 | 0.2736 |
10:20 ET | 171939 | 0.2607 |
10:22 ET | 34487 | 0.2692 |
10:24 ET | 7295 | 0.2681 |
10:26 ET | 21282 | 0.2658 |
10:27 ET | 2589 | 0.2669 |
10:29 ET | 5344 | 0.2637 |
10:33 ET | 4888 | 0.2668 |
10:36 ET | 19149 | 0.269 |
10:38 ET | 35153 | 0.270857 |
10:40 ET | 16105 | 0.2725 |
10:42 ET | 8308 | 0.2682 |
10:44 ET | 3715 | 0.272999 |
10:45 ET | 7154 | 0.2682 |
10:47 ET | 7766 | 0.2688 |
10:49 ET | 26795 | 0.2712 |
10:51 ET | 7070 | 0.2699 |
10:54 ET | 4784 | 0.2708 |
10:56 ET | 22514 | 0.267 |
10:58 ET | 2040 | 0.265301 |
11:00 ET | 260 | 0.2703 |
11:02 ET | 1246 | 0.2656 |
11:03 ET | 5469 | 0.2693 |
11:05 ET | 16580 | 0.2675 |
11:07 ET | 46041 | 0.2653 |
11:09 ET | 50829 | 0.27 |
11:12 ET | 371 | 0.2655 |
11:14 ET | 15146 | 0.2704 |
11:16 ET | 36210 | 0.2693 |
11:18 ET | 30597 | 0.267501 |
11:20 ET | 2635 | 0.2699 |
11:21 ET | 4825 | 0.2711 |
11:23 ET | 3586 | 0.269001 |
11:25 ET | 6847 | 0.2703 |
11:27 ET | 6609 | 0.2729 |
11:30 ET | 273 | 0.2725 |
11:32 ET | 3585 | 0.2733 |
11:34 ET | 11190 | 0.271 |
11:36 ET | 8028 | 0.2732 |
11:38 ET | 28026 | 0.273 |
11:39 ET | 4096 | 0.2748 |
11:41 ET | 1217 | 0.2748 |
11:43 ET | 11695 | 0.276 |
11:45 ET | 9783 | 0.2769 |
11:48 ET | 50148 | 0.271 |
11:52 ET | 37020 | 0.2739 |
11:54 ET | 7783 | 0.26931 |
11:56 ET | 6712 | 0.2738 |
11:57 ET | 3641 | 0.2744 |
11:59 ET | 3134 | 0.27 |
12:01 ET | 7300 | 0.2745 |
12:03 ET | 100 | 0.2746 |
12:06 ET | 8384 | 0.2746 |
12:08 ET | 14755 | 0.277868 |
12:10 ET | 6631 | 0.2741 |
12:12 ET | 100 | 0.2741 |
12:14 ET | 4054 | 0.2741 |
12:15 ET | 6056 | 0.2714 |
12:17 ET | 3200 | 0.2733 |
12:19 ET | 4623 | 0.2741 |
12:21 ET | 2730 | 0.2725 |
12:24 ET | 9975 | 0.2716 |
12:26 ET | 7379 | 0.2709 |
12:28 ET | 7183 | 0.2721 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Syros Pharmaceuticals Inc | 6.7M | -0.1x | --- |
BioNexus Gene Lab Corp | 4.3M | -6.1x | --- |
Jaguar Health Inc | 11.7M | -0.1x | --- |
LakeShore Biopharma Co Ltd | 56.9M | -0.5x | --- |
Medicure Inc | 7.4M | -3.9x | --- |
Rosetta Genomics Ltd | 590.0 | 0.0x | --- |
Syros Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing new standards of care for the frontline treatment of patients with hematologic malignancies. The Company is advancing Tamibarotene, a selective retinoic acid receptor alpha (RARα), agonist for which the Company is conducting SELECT-MDS-1, a Phase III clinical trial evaluating tamibarotene in combination with azacitidine in a genomically defined subset of patients with higher-risk myelodysplastic syndrome (HR-MDS), and for which it is conducting SELECT-AML-1, a randomized Phase II clinical trial evaluating tamibarotene in combination with venetoclax and azacitidine in a genomically defined subset of newly diagnosed patients with acute myeloid leukemia (AML). Its other assets include SY-2101 and SY-5609. The Company is seeking out-licensing opportunities for the further development of SY-5609, its highly selective and potent inhibitor of cyclin dependent kinase 7 (CDK7).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $6.7M |
---|---|
Revenue (TTM) | $386.0K |
Shares Outstanding | 26.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.37 |
EPS | $-3.03 |
Book Value | $0.63 |
P/E Ratio | -0.1x |
Price/Sales (TTM) | 17.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -28,927.20% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.